Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Series D
Biotech
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
BioAge's $170 million series D pushes the company's cash runway into at least late 2026.
Max Bayer
Feb 13, 2024 8:00am
Fierce Biotech Fundraising Tracker: Kimia, Sudo & more
Dec 20, 2023 7:00am
Beta Bionics brings in $100M to expand artificial pancreas tech
Aug 31, 2023 10:37am
ElevateBio hits 2023 high with $401M series D
May 24, 2023 6:00am
Home kidney test developer Healthy.io touts $50M VC backing
May 3, 2023 4:05pm
Former J&J R&D chief Mathai Mammen lands at FogPharma
Mar 30, 2023 6:00am